Catalyst Wire Dossier Catalyst Wire Dossier

Bezuclastinib

bezuclastinib · Cogent Biosciences
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Bezuclastinib, covering 2025-10-31 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: (Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis [Phase 2]

See pricing